250+ investors that invest in your industry and stage Get
Any industry
Energy
Proptech
Community
Health Care
Gaming
Artificial Intelligence
Climate
Biotech
Impact
Google
EdTech
Sustainability
Venture Capital
Clean Energy
Finance
Digital Media
Local
Enterprise Software
Email
Travel
Recruiting
Platforms
Fitness
Wine and Spirits
Crowdfunding
Social
CleanTech
Mobile Apps
InsurTech
LGBT
Retail
Infrastructure
Oil and Gas
Fashion
Theatre
Social Impact
Non Profit
Renewable Energy
Sporting Goods
Celebrity
Cryptocurrency
SaaS
Restaurants
Machine Learning
Facebook
Agriculture (AgTech)
Media (Entertainment)
Blockchain
Beauty
Publishing
Food and Beverage
Social Network
Web3
Big Data
Organic Food
Video Games
Medical Device
Medical
Wellness
Education
Payments
Art
Social Media
Photography
Music
Franchise
Android
Mobile
Internet
Legal
Construction
eSports
Manufacturing
Sports
Automotive
Hospitality
Financial Services
Mobile Advertising
Cannabis
Biotechnology
FinTech
Consumer
Marketplace
Hardware
Transportation
Real Estate
Life Science
B2B
Film
Enterprise
Software
Any country
Australia
South Korea
Europe
Brazil
Indonesia
Singapore
Saudi Arabia
Africa
Oceania
LATAM
Asia
Middle East
Costa Rica
Gibraltar
Bahrain
Greece
Finland
Liberia
Mexico
Lebanon
Norway
Mauritius
Italy
Israel
Taiwan
Tunisia
Zambia
Russian Federation
Tajikistan
Sweden
Zimbabwe
Togo
Puerto Rico
Algeria
San Marino
Jamaica
Nigeria
Honduras
Isle of Man
Mozambique
Luxembourg
Albania
Pakistan
Romania
Bangladesh
Kazakhstan
Kenya
Cayman Islands
Cambodia
Oman
Cameroon
Colombia
Guatemala
Seychelles
Ireland
China
Japan
Qatar
South Africa
Spain
Sri Lanka
Armenia
Azerbaijan
Austria
Barbados
Argentina
Vietnam
United Arab Emirates
Bulgaria
Belarus
Estonia
Belgium
Bermuda
Bolivia
Egypt
France
Bahamas
Czech Republic
Chile
Denmark
Faroe Islands
Georgia
Ecuador
Belize
Croatia
Dominican Republic
Hong Kong
Switzerland
Ethiopia
Grenada
Ghana
Iraq
Hungary
Iceland
Jersey
Jordan
Kuwait
Liechtenstein
Lithuania
Morocco
Latvia
Mali
Marshall Islands
Myanmar
Malta
Malaysia
Nicaragua
Namibia
Peru
Philippines
Poland
Panama
Portugal
Rwanda
Sierra Leone
Serbia
Slovenia
Senegal
El Salvador
Thailand
Tanzania
Uruguay
Turkey
Ukraine
Uganda
Uzbekistan
Venezuela
United States
New Zealand
Cyprus
India
Germany
Canada
United Kingdom
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Find investors

Top 50 Biotechnology VC Funds & Investors in Middle East (June 2026)

The most active venture capital funds investing in Middle East Biotechnology startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Middle East Biotechnology startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Trendlines Group
VC Fund
17 Israel, Singapore, United Kingdom Seed, Series A Health Care, Biotechnology, Medical Device $650k–$15M
Pontifax
VC Fund
16 United States, Israel, France Series A, Series B, Series C Biotechnology, Health Care, Pharmaceutical $4M–$104M
Israel Innovation Authority
VC Fund
12 Israel, United States, Mali Grant, Seed, Pre-Seed Health Care, Biotechnology, Medical Device $100k–$6M
OurCrowd
VC Fund
10 Israel, United States, New Zealand Series B, Series A, Seed Software, Artificial Intelligence, Health Care $612k–$70M
TRANGELS
VC Fund
10 Turkey, United States, Estonia Seed, Pre-Seed, Angel Software, Information Technology, Biotechnology $24k–$1.4M
OrbiMed
VC Fund
7 United States, China, Israel Series B, Series A, Series C Biotechnology, Health Care, Medical $10M–$150M
aMoon Fund
VC Fund
7 United States, Israel, France Series B, Series A, Series C Health Care, Biotechnology, Medical $5.7M–$93M
Docor International Management
VC Fund
6 Israel, United States Series C, Series A Health Care, Biotechnology, 3D Technology $13M–$22M
Arkin Holdings
VC Fund
6 Israel, United States, Switzerland Series A, Series B, Seed Biotechnology, Health Care, Medical $2M–$95M
ZORA Ventures
VC Fund
5 Israel, United States, United Kingdom Seed, Series A, Convertible Note Health Care, Biotechnology, Internet $1M–$7M
HBL Hadasit Bio Holdings
VC Fund
5 Israel Series A, Series B Biotechnology, Medical, Health Care
Takeda Ventures
VC Fund
4 United States, United Kingdom, Israel Series A, Series B Biotechnology, Health Care, Therapeutics $10M–$130M
Johnson & Johnson Robotics and Digital Solutions
VC Fund
4 United States, Israel, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $300k–$100M
iAngels
VC Fund
4 United States, Israel, United Kingdom Seed, Series A Software, Artificial Intelligence, Financial Services $1M–$22M
New York Ventures
VC Fund
4 United States, Canada, Israel Seed, Series A, Series B Health Care, Biotechnology, Software $1.5M–$53M
Sapir Venture Partners
VC Fund
4 Israel, United States, United Kingdom Seed, Pre-Seed, Series A Software, Biotechnology, Machine Learning $1.3M–$40M
Grove Ventures
VC Fund
4 Israel, United States Seed, Series A, Series B Artificial Intelligence, Software, Machine Learning $3.5M–$74M
Integra Holdings
VC Fund
4 Israel Seed, Series B, Series F Biotechnology, Pharmaceutical, Life Science
Clal Biotechnology Industries
VC Fund
4 Israel, United States Series A, Series B Health Care, Biotechnology, Medical $4M–$55M
Diffusion Capital Partners
VC Fund
4 Turkey, United States, United Kingdom Seed, Series A Software, Information Technology, Artificial Intelligence $439k–$2.7M
Egypt Ventures
VC Fund
3 Egypt, Ireland, United States Seed, Pre-Seed, Series A Software, Information Technology, E-Commerce $28k–$3M
Millenium Food-Tech
VC Fund
3 Israel Seed, Series A, Convertible Note Food and Beverage, Manufacturing, Retail $2.5M–$15M
Welltech Ventures
VC Fund
3 Israel, United States Seed, Pre-Seed mHealth, Health Care, Biotechnology $1.9M–$19M
Office of the Chief Scientist
VC Fund
3 Israel Seed Health Care, Biotechnology, Hardware $500k–$1M
Siddhi Capital
VC Fund
3 United States, Israel, Canada Seed, Series A, Series B Food and Beverage, Biotechnology, Nutrition $1.7M–$106M
SciSparc
VC Fund
3 Israel Corporate Round Pharmaceutical, Cannabis, Biopharma $400k–$700k
ACT Venture Partners
VC Fund
3 Turkey, United States, United Kingdom Seed, Series A, Convertible Note Artificial Intelligence, Software, Biotechnology $345k–$9M
fresh.fund
VC Fund
3 Israel, United States, Norway Seed, Pre-Seed, Series A Health Care, Artificial Intelligence, Software $120k–$21M
Binder & Partners Ventures
VC Fund
3 Israel, France, United States Seed, Pre-Seed, Series A Software, Information Technology, Computer $8M–$14M
Cancer Focus Fund
VC Fund
3 Israel, United States, Germany Series A, Seed Biotechnology, Medical, Health Care $5.4M–$28M
FutuRx
VC Fund
3 Israel Seed Biotechnology, Life Science, Biopharma
Kinisis Ventures
VC Fund
3 Cyprus, United States, United Kingdom Seed, Series A Manufacturing, Biotechnology, Internet of Things $1.1M–$2M
Accelmed
VC Fund
3 Israel, United States Series D, Series A Health Care, Medical Device, Medical $695k–$96M
Nevateam Partners
VC Fund
3 Israel Seed, Series A AgTech, SaaS, Farming $5M–$10M
Milk & Honey Ventures
VC Fund
3 Israel Pre-Seed, Seed, Series A Biotechnology, Food and Beverage, Nutrition $1.8M–$1.9M
GlenRock Israel
VC Fund
3 Israel, United States Seed, Series B, Series A Software, Cyber Security, Health Care $100k–$19M
Consensus Business Group
VC Fund
3 Israel, United States, United Kingdom Seed, Series A Health Care, Medical Device, Medical $1M–$10M
Neo Ventures
VC Fund
3 Israel, United Kingdom, Estonia Seed, Series A Software, Artificial Intelligence, Aerospace
Ziegler Meditech Equity Partners
VC Fund
3 United States, Israel Series C, Series E, Series F Health Care, Biotechnology, Mobile
EIT Food
VC Fund
3 United Kingdom, Israel, Germany Grant, Seed Food and Beverage, Biotechnology, Food Processing $30k–$11M
SOSV
VC Fund
3 United States, India, United Kingdom Seed, Convertible Note, Pre-Seed Biotechnology, Health Care, Software
Istcapital
VC Fund
3 Turkey, United States Seed, Series A Biotechnology, Beauty, Gaming $1M–$2.5M
Pitango VC
VC Fund
3 Israel, United States, China Series A, Series B, Series C Software, Health Care, Information Technology $4M–$100M
Aurum Ventures MKI
VC Fund
2 Israel Seed, Series A, Series C Biotechnology, Medical Device, Information Technology
MoreVC
VC Fund
2 Israel, United States, Canada Series A, Seed Software, Energy, Renewable Energy
Endure Capital
VC Fund
2 Egypt, United States, United Kingdom Seed, Series A, Series B Software, Health Care, Artificial Intelligence
Chartered Opus
VC Fund
2 Israel Series A Wellness, Biotechnology, Manufacturing
The Food Tech Lab
VC Fund
2 Israel, Spain, Sweden Seed, Pre-Seed Biotechnology, Manufacturing, Food and Beverage
HackCapital
VC Fund
2 United States, Israel, United Kingdom Seed, Pre-Seed, Series A Biotechnology, Food and Beverage, Food Processing
Arancia International
VC Fund
2 Israel, United States, Malaysia Series A, Series B Health Care, Biotechnology, Life Science
Access all 50 VC funds in Middle East Biotechnology startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Trendlines Group
VC Fund · Misgav, HaZafon, Israel · 17 investments in Middle East Biotechnology startups

Trendlines Group invents, discovers, invests in, and incubates innovation-based medical and agrifood technologies. Trendlines invests principally through medical and agrifood incubators in Israel and in Singapore, its in-house innovation center, Trendlines Labs, and its Funds - the Trendlines Agrifood Fund and the Bayer Trendlines Ag InnovationFund.The company was founded in 1993 and is headquartered in Misgav, Israel.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Seed, Series A
  • Geography: Israel, Singapore, United Kingdom

Investor stats

  • Total investments: 67
  • Round size: Seed $650k–$3.2M; Series A $2.3M–$15M
  • Lead/follow: 21% lead, 79% follow
  • Last fund: May invest from a new fund soon — raised $40M in 2019

Portfolio highlights

  • IBI-Ag — IBI-Ag is a biotechnology company developing a new class of bioinsecticides. IBI-Ag is focused on the discovery and development of new types of biological solutions that utilize environmentally friendly technology to control insects. IBI-Ag utilizes breakthrough technology to produce efficient, selective, and safe bio-insect control solutions.IBI-Ag technology is highly cost-effective due to its fermentation suitability enabling farmers to produce agricultural produce at a low cost.
  • Celleste Bio — Celleste is a business that specializes in employing cell culture techniques to produce high-value cocoa ingredients, removing the need for cocoa trees to be grown.
  • Arcuro Medical — Arcuro develops a new repair system for meniscus tears of the knee. Arcuro’s proprietary SuperBall repair system consists of a knotless, all-suture anchor and innovative delivery system. The company was founded in 2013.
Show all investments...

Pontifax
VC Fund · Herzliya, Tel Aviv, Israel · 16 investments in Middle East Biotechnology startups

Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Israel, France

Investor stats

  • Total investments: 106
  • Round size: Series A $4M–$95M; Series B $20M–$100M; Series C $12M–$104M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — raised $14M in 2020

Portfolio highlights

  • Abcuro — Precision Targeting of Highly Cytotoxic T Cells in Autoimmune Disease.
  • Step Pharma — Step Pharma is a spin-off of Imagine Institute stemming from Pr. Alain Fischer’s research on genetic immunodeficiencies. Step Pharma is a joint venture between Imagine, a research and innovative healthcare institute, Sygnature Discovery, a leading provider of integrated drug discovery resource and expertise, and Kurma Partners, a major player inthe funding of healthcare and biotechnology in Europe.
  • Applied Immune Technologies — Applied Immune Technologies Ltd. engages in development of therapeutic molecules for cancer, viral, and autoimmune diseases. The company develops T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for various therapeutic and diagnostic applications. Its TCRL antibodies also have diagnostic applications inpathology; and vaccine design, validation, and monitoring, as well as in the analysis of antigen presentation in disease. The company was formerly known as BioMimic Pharma. The company was founded in 2006 and is based in Haifa, Israel.
Show all investments...

Israel Innovation Authority
VC Fund · Jerusalem, Yerushalayim, Israel · 12 investments in Middle East Biotechnology startups, 9 in the past 12 months

The Israel Innovation Agency, the Innovation Authority, was established in 1965 as the Office of the Chief Scientist of the Ministry of Industry and Trade and was designed as a body that supports R & D conducted in the framework of government research institutes. Industrial development in order to increase industrial exports of high-techproducts. The Chief Scientist focused on reducing the risk by participating in financing the project, which the private companies chose and led.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Grant, Seed, Pre-Seed
  • Geography: Israel, United States, Mali

Investor stats

  • Total investments: 141
  • Round size: Seed $590k–$6M; Grant $100k–$3.5M; Pre-Seed $150k–$2.5M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Q-Factor
  • Sub-Q Bionics — Sub-Q Bionics is a medtech company, that aids the management of chronic pain and debilitating symptoms of lymphedema specially for women.
  • Scala Biodesign — At Scala Biodesign, we provide our partners a unique one-shot computational protein design solutions to dramatically increase the value and accelerate the development of proteins into commercial products.
Show all investments...

OurCrowd
VC Fund · Jerusalem, Yerushalayim, Israel · 10 investments in Middle East Biotechnology startups

Invest in exclusive and pre-vetted startups, late-stage companies, and top tier funds - private market access made simple, transparent, and institutional-grade.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Series B, Series A, Seed
  • Geography: Israel, United States, New Zealand

Investor stats

  • Total investments: 261
  • Round size: Seed $612k–$8M; Series A $5.3M–$22M; Series B $8M–$70M
  • Lead/follow: 18% lead, 82% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Corgi Insurance — Corgi Insurance Services, Inc. ("Corgi") is an American technology company that operates an artificial intelligence (AI)-powered insurance carrier based in San Francisco, California. Corgi Insurance develops and operates a fully integrated insurance stack using AI agents to automate traditional carrier operations, becoming the world’sfirst “AI insurance company.” The company owns multiple subsidiaries operating under a dog-themed naming convention.
  • PhenOlives — PhenOlives transforms olive oil waste into nutritious, gluten-free olive flour that retains the health benefits of olive oil. The company employs a patented process to create a high-fiber ingredient suitable for various baking and cooking applications.
  • BetterSeeds — The company focuses on non-GMO genome editing using CRISPR-Cas9 for creating a novel breed of seeds and crop traits that address the 21st-century agriculture challenges. BetterSeeds provides advanced seeds enabling better crops for mechanized harvesting, extreme e climate resistance, higher calory and nutrient values, and more.
Show all investments...

TRANGELS
VC Fund · Istanbul, Istanbul, Turkey · 10 investments in Middle East Biotechnology startups

Early Stage Investment Fund and Network

Show more...

Investment focus

  • Industry: Software, Information Technology, Biotechnology
  • Stage:Seed, Pre-Seed, Angel
  • Geography: Turkey, United States, Estonia

Investor stats

  • Total investments: 59
  • Round size: Seed $52k–$1.4M; Angel $24k–$500k; Pre-Seed $29k–$400k
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • PackUpp — PackUpp is a new generation on-demand “Fast Delivery” technology company and we provide E-Commerce delivery solutions. We serve “Next-Day”, "Same-Day" and "3 Hours Express" deliveries to e-commerce companies. In addition to it, we form “Private Dedicated Field Delivery Teams” to companies as a special delivery team of brand. Wedigitalize all the delivery process by our unique software and technology.Focus on the job which you are best at! Rest, all your packages will be delivered by PackUpp, Fast Delivery Expert.
  • Salty Enerji — Salty Enerji is a manufacturing company that designs energy storage infrastructure to enhance renewable power efficiency and distribution.
  • Weddingbouquet.com — DüğünBuketi is a web and special event organization portal that brings wedding firms together to get price quotes. It was founded in 2017 and is based in Izmir, Turkey.
Show all investments...

OrbiMed
VC Fund · New York, New York, United States · 7 investments in Middle East Biotechnology startups

Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, China, Israel

Investor stats

  • Total investments: 576
  • Round size: Series A $10M–$116M; Series B $24M–$150M; Series C $15M–$131M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Sonendo — Sonendo developing innovative technologies to transform dentistry by Saving Teeth Through Sound Science®. The GentleWave® System shows significant improvements in clinical efficacy and practice efficiency when compared to standard root canal treatment.1,2, 3 Sonendo is the parent company of TDO® Software, the developer of the most widely usedendodontic practice management software in the world, designed to simplify practice workflow. TDO software seamlessly integrates practice management, imaging, social media, referral reporting, CBCT imaging, and offers built-in communication with the GentleWave System.
  • resTORbio — Restore Beauty - Rethink Bio
  • Caris Life Sciences — Caris fulfills the promise of precision oncology through advanced laboratory testing, including tumor profiling and blood-based cancer diagnostics.
Show all investments...

aMoon Fund
VC Fund · Ra'anana, HaMerkaz, Israel · 7 investments in Middle East Biotechnology startups, 6 in the past 12 months

aMoon is a leading healthtech & life sciences venture fund founded by Marius Nacht and Dr. Yair Schindel. Their team is passionate about building successful businesses and helping biopharma, digital health and medical technology companies realize their potential. They partner with management teams who use technology and cutting-edge science toaccelerate cures for the world’s most life-threatening conditions and those providing solutions for global healthcare’s biggest cost drivers.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, Israel, France

Investor stats

  • Total investments: 75
  • Round size: Series A $5.7M–$83M; Series B $22M–$93M; Series C $30M–$82M
  • Lead/follow: 51% lead, 49% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Adcytherix — Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer.
  • Lin Health — Online chronic pain recovery program designed to get you back to the life you want to live. One-on-one coaching. Real pain reduction results.
  • KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
Show all investments...

Docor International Management
VC Fund · Tel Aviv, Tel Aviv, Israel · 6 investments in Middle East Biotechnology startups

Docor International B.V. is a fully-owned subsidiary of Crecor B.V. Both Docor and Crecor were formed as wholly-owned subsidiaries of the Van Leer Group Foundation to promote and participate in commercial activities in Israel.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, 3D Technology
  • Stage:Series C, Series A
  • Geography: Israel, United States

Investor stats

  • Total investments: 14
  • Round size: Series C $13M–$22M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Check-Cap — Check-Cap Ltd. is merging with MBody AI to create a leading publicly traded embodied AI company powering autonomous workforces.
  • Ocon Healthcare — OCON Healthcare innovates, develops, manufactures, and commercializes cutting-edge women’s health products based on our patented IUB™ (Intra Uterine Ball) proprietary platform. The IUB™, made from a super-elastic alloy Nitinol, is an ideal carrier for multiple drugs to the uterus to treat a variety of conditions.In addition to our flagshipproduct, the IUB™ Ballerine®, OCON healthcare is developing an innovative pipeline of products utilizing the IUB™ frame for indications such as abnormal uterine bleeding (AUB), heavy menstrual bleeding (HMS), myomas/fibroids, and infertility.
  • Raziel Health — Raziel Health’s mission is to bring world-class, disruptively less expensive healthcare to everyone, in the comfort of their home. Its unique, integrated system combines easy-to-use technologies that support positive patient experience, enable timely clinical intervention, and meet individual patient goals while using data analytics to supportwellness and disease management.
Show all investments...

Arkin Holdings
VC Fund · Herzliya, Tel Aviv, Israel · 6 investments in Middle East Biotechnology startups

Explore Arkin Capital: A leading multi-asset manager driving strategic investments across health, technology, equity, real estate and more

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Seed
  • Geography: Israel, United States, Switzerland

Investor stats

  • Total investments: 31
  • Round size: Seed $2M–$6M; Series A $15M–$29M; Series B $23M–$95M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: Likely still investing — raised $270M in 2021

Portfolio highlights

  • Lendbuzz — Lendbuzz is an AI-based auto finance platform that helps consumers with thin or no credit history obtain financing when purchasing a car. Powered by machine learning and proprietary algorithms, Lendbuzz is able to better assess the creditworthiness of consumers with limited credit history, who are underserved by the traditional banks. By partneringwith auto dealerships, Lendbuzz is able to offer consumers attractive financing solutions and dealerships are able to close additional business opportunities and serve a more diversified client base. Lendbuzz is headquartered in Boston, Massachusetts and was founded in 2015.
  • Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
  • Nocion Therapeutics — Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation. The company is developing "nocions" which are a new kind of therapy that selectively affects actively firing nociceptors, enabling patients to provide targeted, robust and sustained relief for the treatment ofserious conditions including cough, itch, pain and inflammation.
Show all investments...

ZORA Ventures
VC Fund · Tel Aviv, Tel Aviv, Israel · 5 investments in Middle East Biotechnology startups

Impact investing in Israeli technology. ZORA is an impact investing fund investing in early-stage Israeli companies solving global challenges in health, education, economic inclusion and the environment.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Internet
  • Stage:Seed, Series A, Convertible Note
  • Geography: Israel, United States, United Kingdom

Investor stats

  • Total investments: 13
  • Round size: Seed $1M–$7M; Series A $4M–$6M
  • Lead/follow: 8% lead, 92% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • BiotaX — Microbiome Genomic Analysis Cloud Platform | Biotax.co
  • Newmoo — Newmoo makes plant-based cheeses and dairy alternatives.
  • Forsea Foods — Forsea Foods develops cell-cultured seafood through the use of patented organoid technology which allows them to bypass the scaffolding stage of cultivated meat production.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
HBL Hadasit Bio Holdings
VC Fund · Jerusalem, Yerushalayim, Israel · 5 investments in Middle East Biotechnology startups

Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE : HDST ) and recently on the OTC (OTCBB : HADSY ) in order to allow public participation in the highly promising field of biotechnology.It serves as a precedent in biotech financing - for the first time, public investment is allowed toparticipate in a holding entity including companies based on IP generated by Israel’s foremost medical research center – Hadassah University Hospital ("HU").In addition to the public holdings (54%) – including major Israeli institutional investors, HBL is held by Hadasit (www.hadasit.co.il) (36%) and Consensus Business Group (http://www.consensusbusiness.com) (10%). The traded stock, as a unique investment vehicle, provides investment exposure to a select cluster of 6 biotech companies - all based on inventions developed and owned by HU.HBL is a publicly traded subsidiary of Hadasit Ltd. – the technology transfer company of the Hadassah University Hospital in Jerusalem, Israel. Hadasit was established for the purpose of promoting and commercializing the intellectual property (IP) and R&D capabilities generated by Hadassah, aimed at finding solutions to problems faced by modern medicine.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A, Series B
  • Geography: Israel

Investor stats

  • Total investments: 9
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • ProtAb — ProtAb develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune and inflammatory diseases. Its first product, Prozumab, is a monoclonal antibody with a novel mechanism of action. It is currently in late-stage preclinical development for thetreatment of inflammatory bowel disease or IBD, ulcerative colitis or UC, and rheumatoid arthritis or RA. It operates as a subsidiary of Hadasit Bio-Holdings. HBL is a publicly traded subsidiary of Hadasit, the technology transfer company of the Hadassah University Hospital in Jerusalem in Israel.
  • KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
  • Enlivex Therapeutics — Enlivex is a clinical-stage macrophage reprogramming immunotherapy company that targets diseased macrophages in patients with sepsis. The company develops an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn'sDisease, and other autoimmune and inflammatory disorders.The company's revolutionary approach is to induce immune tolerance by injecting apoptotic cells and facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity.Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells.
Show all investments...

Takeda Ventures
VC Fund · San Diego, California, United States · 4 investments in Middle East Biotechnology startups

Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC. They are based alongside Takeda’s R&D sites in Cambridge, MA, and San Diego, CA. As a strategic investor, TVI aims to provide support and guidance toentrepreneurs and early-stage companies driving concepts through clinical proof of concept. They also strive to forge active, collaborative interactions that result in synergies with Takeda's considerable R&D resources. Their goal is to build a portfolio of strategic investments, with an immediate emphasis on oncology, gastroenterology, neuroscience, and rare diseases.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 103
  • Round size: Series A $10M–$58M; Series B $20M–$130M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • Degron Therapeutics — Degron Therapeutics is a leading platform company in discovery of molecular glue degraders for cancer treatment.
  • Accipiter Biosciences — Accipiter Biosciences is a biotechnology company.
  • Harness Therapeutics — Transine Therapeutics is a private biotechnology company focused on the development of a novel class of therapeutic RNAs that can upregulate protein expression with an unprecedented level of control and specificity: the SINEUPs®. The company's pioneering technology is expected to offer an entirely unique mechanism of action for currentlyhard-to-treat diseases by massively extending the druggable proteome and allowing it to address diseases that have been beyond the reach of small molecules, conventional biologics, or gene therapies.
Show all investments...

Johnson & Johnson Robotics and Digital Solutions
VC Fund · New Brunswick, New Jersey, United States · 4 investments in Middle East Biotechnology startups

Healthcare innovation wherever it originates.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Israel, United Kingdom

Investor stats

  • Total investments: 70
  • Round size: Series A $5.9M–$63M; Series B $18M–$55M; Series C $300k–$100M
  • Lead/follow: 23% lead, 77% follow

Portfolio highlights

  • Moon Surgical — Create the OR of the future, one that is sustainable, efficient, and digitalized.
  • Artera — Discover the power of Personalized Precision Medicine & AI Cancer Therapy with Artera. Transforming cancer therapy through innovation.
  • ONL Therapeutics — ONL Therapeutics develops innovative therapeutics to protect and improve the vision of patients with a range of retinal diseases and conditions.
Show all investments...

iAngels
VC Fund · Tel Aviv, Tel Aviv, Israel · 4 investments in Middle East Biotechnology startups

Invest in groundbreaking startups with iAngels. Discovercutting-edge technology and join a community of forward-thinking investors shapingthe future of entrepreneurship.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Financial Services
  • Stage:Seed, Series A
  • Geography: United States, Israel, United Kingdom

Investor stats

  • Total investments: 120
  • Round size: Seed $1M–$10M; Series A $4.5M–$22M
  • Lead/follow: 8% lead, 92% follow
  • Last fund: Likely still investing — raised $56M in 2021

Portfolio highlights

  • Nas Daily
  • Wild Moose — Wild Moose helps on-call developers more quickly identify the source of production incidents, by providing a conversational AI trained on their environment. This allows developers to delegate the search through logs and metrics to lightning-fast AI.
  • Lava Network — Lava Network aims to be a marketplace for blockchain data.
Show all investments...

New York Ventures
VC Fund · New York, New York, United States · 4 investments in Middle East Biotechnology startups

New York Ventures is dedicated to encouraging innovation and fueling economic growth in communities across the State. This venture capital investment arm of Empire State Development is one of New York State's business resources and innovation investments, including the Governor's START-UP NY program, Innovation Hot Spots, the RegionalEconomic Development Councils, the Centers of Advanced Technology and Centers of Excellence networks, and the SUNY 2020 Initiative.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Seed, Series A, Series B
  • Geography: United States, Canada, Israel

Investor stats

  • Total investments: 118
  • Round size: Seed $1.5M–$7M; Series A $3M–$20M; Series B $2.5M–$53M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • Fathom Therapeutics — Fathom Therapeutics, previously known as Atommap, is a biotechnology company focused on designing therapeutic molecules through computational drug discovery approaches. The company develops models that simulate biomolecular and protein motion to better understand how proteins behave and interact, enabling the identification of new therapeuticstrategies. Its platform combines generative design, predictive modeling, and computational assays to create and evaluate molecular candidates for their binding affinity and functional effects. By leveraging these simulations, it supports drug discovery processes such as hit identification, lead optimization, and the design of targeted molecules, including degraders and molecular glues. The company also collaborates with partners by providing molecular designs, predictive insights, and co-development opportunities for advancing therapeutic candidates.
  • Adro — Designed to work when you arrive Spend and save like a local. Easy to use. No unfair fees.
  • CREW Carbon — CREW provides wastewater treatment facilities with a process intensification solution that improves performance, lowers costs, and permanently removes greenhouse gasses.
Show all investments...

Sapir Venture Partners
VC Fund · 4 investments in Middle East Biotechnology startups

Early Stage VC

Show more...

Investment focus

  • Industry: Software, Biotechnology, Machine Learning
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Israel, United States, United Kingdom

Investor stats

  • Total investments: 20
  • Round size: Seed $1.3M–$5M; Series A $10M–$40M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
  • Lidwave — Lidwave’s deep-tech solution revolutionizes 3D sensing and the verticals relying on it by examining the biggest challenge in LiDAR technology from a new perspective, free of bandwidth limitations.
  • DeepCure — DeepCure is a Boston-based therapeutics company that harnesses advanced AI, physics-based tools and automation to discover novel small molecules for challenging targets. DeepCure currently has a lead asset in IND-enabling studies and other programs focused on drugging intractable targets that have t
Show all investments...

Grove Ventures
VC Fund · Tel Aviv, Tel Aviv, Israel · 4 investments in Middle East Biotechnology startups, 6 in the past 12 months

Grove Ventures is a leading early-stage venture capital fund in Israel. It partners early with exceptional Israeli founders who believe th...

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Machine Learning
  • Stage:Seed, Series A, Series B
  • Geography: Israel, United States

Investor stats

  • Total investments: 68
  • Round size: Seed $3.5M–$20M; Series A $8M–$50M; Series B $20M–$74M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: Likely still investing — raised $185M in 2022

Portfolio highlights

  • Niv-AI — Niv-AI develops an AI platform that optimizes power usage in AI data centers by capturing real-time electricity consumption data and dynamically balancing workloads. It addresses bottlenecks where synchronized GPUs create sharp power spikes, unlocking up to 30% of stranded capacity without new hardware.
  • NoTraffic — NoTraffic has developed the first AI-powered traffic signal platform that connects road...
  • Scala Biodesign — At Scala Biodesign, we provide our partners a unique one-shot computational protein design solutions to dramatically increase the value and accelerate the development of proteins into commercial products.
Show all investments...

Integra Holdings
VC Fund · Wallisellen, Zurich, Switzerland · 4 investments in Middle East Biotechnology startups

Our expert team is the first to examine and evaluate the Hebrew University's biomedical breakthroughs. We then capitalize decades of experience - transforming the inventions into pioneering companies. Our golden eggs Ayana Pharma A late stage company with

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Life Science
  • Stage:Seed, Series B, Series F
  • Geography: Israel

Investor stats

  • Total investments: 8
  • Lead/follow: 75% lead, 25% follow

Portfolio highlights

  • BacoCure — BacoCure is developing a novel bacterial product for local therapy of non-muscle invasive bladder cancer (NMIBC) patients.
  • Splisense — Transformative RNA Based Treatments -Antisense Oligonucleotides- Targeting the Root Cause of Pulmonary Diseases Our innovative RNA based therapies, based on Antisense Oligonucleotides (ASOs), restore and modify protein functionality, addressing untreatable pulmonary diseases.
  • Rebiotic Rx — Develops nanotechnology-based antibiotics with the focus on resistant bacteria
Show all investments...

Clal Biotechnology Industries
VC Fund · Tel Aviv, Tel Aviv, Israel · 4 investments in Middle East Biotechnology startups

Clal Biotechnology Industries is a leading Israeli life sciences investment company traded on the Tel Aviv Stock Exchange (TASE: CBI).

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B
  • Geography: Israel, United States

Investor stats

  • Total investments: 14
  • Round size: Series A $4M–$55M; Series B $15M–$33M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • Sight Diagnostics — Combining AI and breakthrough hardware to bring lab-quality CBC results to the doctor's office.
  • Cadent Therapeutics — Cadent Therapeutics is a precision neuroscience company developing novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease. The company leverages its precision neuroscience approach combining target specificity, patient selection, drug design and optimization, andnovel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders.It was founded in 2010 and headquartered in Cambridge, Massachusetts.
  • Elicio Therapeutics — Elicio ground-breaking Amphiphile technology is engineering potent vaccines and immunotherapies to defeat an array of aggressive cancers.
Show all investments...

Diffusion Capital Partners
VC Fund · Istanbul, Istanbul, Turkey · 4 investments in Middle East Biotechnology startups

Diffusion Capital Partners (DCP) is Turkey's leading Venture Capital fund manager with a focus on deep-tech opportunities.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Series A
  • Geography: Turkey, United States, United Kingdom

Investor stats

  • Total investments: 49
  • Round size: Seed $439k–$2.7M; Series A $985k–$2.5M
  • Lead/follow: 63% lead, 37% follow
  • Last fund: May invest from a new fund soon — raised $32M in 2020

Portfolio highlights

  • Boby.ai — Boby.ai develops artificial intelligence-supported mobile applications for end users
  • V-Count — V-Count works with 550+ brands, 25.000+ locations in 105+ countries.
  • PowerDev — PowerDev allows renewable energy contenders to make decisive and sustainable battery storage and green hydrogen investments.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Egypt Ventures
VC Fund · El Cairo, Valle del Cauca, Colombia · 3 investments in Middle East Biotechnology startups

Egypt Ventures is an investment firm that empowers the entrepreneurial ecosystem by investing in accelerators. The firm was founded in 2017 and is based in Columbia.

Show more...

Investment focus

  • Industry: Software, Information Technology, E-Commerce
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Egypt, Ireland, United States

Investor stats

  • Total investments: 23
  • Round size: Seed $100k–$3M; Pre-Seed $28k–$2M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • Educatly — Educatly is a Life Direction Intelligence Platform helping people discover their passions, explore careers, and design the learning paths that shape their future.
  • D OCC Hub — Smart Incident Management Solutions
  • InfiniLink — Empowering Hyperscale Datacenters Building Energy-Efficient Ultra-High-Speed Connectivity Solutions
Show all investments...

Millenium Food-Tech
VC Fund · 3 investments in Middle East Biotechnology startups

Millennium Food-Tech is an R&D partnership traded on the Tel Aviv Stock Exchange that specializes in investment in and betterment of companies in food-tech sectors,. Millennium seeks to invest in companies that specialize in identifying and developing innovative, and transformative ideas in the food, drinks, and nutrition industry. Millenniumhas experienced management, proven solutions, and a supportive network to develop ideas and start-ups from early-stage to maturity to exit.

Show more...

Investment focus

  • Industry: Food and Beverage, Manufacturing, Retail
  • Stage:Seed, Series A, Convertible Note
  • Geography: Israel

Investor stats

  • Total investments: 15
  • Round size: Seed $2.5M–$4.1M; Series A $3.5M–$15M; Convertible Note $4M–$10M
  • Lead/follow: 73% lead, 27% follow

Portfolio highlights

  • ansā — Objectively Awesome Coffee
  • Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
  • Supersmart — Supersmart is the world's leading loss-prevention solution for self-scan transactions. Supersmart uses its proprietary machine-learning, AI algorithm to validate all self-scanning transactions in physical stores. Our solution enables retailers to confidently provide self-scanning options to their customers, enhancing customer experiencewithout sacrificing potential loss.The Israel-based company was founded in 2014 by Yair Cleper and Amir Ayalon.
Show all investments...

Welltech Ventures
VC Fund · Tel Aviv, Tel Aviv, Israel · 3 investments in Middle East Biotechnology startups

Welltech Ventures is Israel’s leading fund focused exclusively on investing in the health and wellness space. We seek to partner with entrepreneurs who epitomize the Startup Nation’s ethos and are building paradigm-shattering companies that are making an impact in the wellness space. As thought leaders we work with global investors focused onaccessing and investing in the Israeli tech ecosystem’s most promising entrepreneurs.

Show more...

Investment focus

  • Industry: mHealth, Health Care, Biotechnology
  • Stage:Seed, Pre-Seed
  • Geography: Israel, United States

Investor stats

  • Total investments: 11
  • Round size: Seed $1.9M–$19M
  • Lead/follow: 45% lead, 55% follow

Portfolio highlights

  • Antidote Health — AntidoteHealth.ai offers primary care on its telehealth app on a 24/7 basis, including prescriptions & more. Book your appointment today!
  • Behavidence — Behavidence is a mental health application that generates a daily mental health score. It compares your digital behavior to other people with anxiety, depression and ADHD.
  • Quris — Quris Technologies is an artificial intelligence (AI) innovator disrupting the pharmaceutical arena.
Show all investments...

Office of the Chief Scientist
VC Fund · Tel Aviv, Tel Aviv, Israel · 3 investments in Middle East Biotechnology startups

The Office of the Chief Scientist [OCS] in the Ministry of Economy is charged with execution of government policy for support of industrial R&D. The goal of the OCS is to assist in the development of technology in Israel as a means of fostering economic growth, encouraging technological innovation and entrepreneurship, leveraging Israel’sscientific potential, enhancing the knowledge base of industry in Israel, stimulating high value-added R&D and encouraging R&D collaboration both nationally and internationally. A variety of ongoing support programs developed and offered by the OCS play a major role in enabling Israel to be a key center for high tech entrepreneurship.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Hardware
  • Stage:Seed
  • Geography: Israel

Investor stats

  • Total investments: 4
  • Round size: Seed $500k–$1M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • LapSpace — LapSpace Medical was founded in 2011. It operates within the framework of the Misgav Venture Accelerator, part of The Trendines Group. The LapSpace team combines strong business and medical experience and knowledge.
  • Sqwik - powered by Geev.Me.Tech LTD — Sqwik is a new way to create, join & follow fun activities, with new friends, within 3 hours.
  • Digma Medical — Digma Medical | DiaGone - safe, one-time, 30 minute, minimaly-invasive, GI procedure for Restoring Glycemic Control for T2DM & NASH patients | No Implant
Show all investments...

Siddhi Capital
VC Fund · Cherry Hill, New Jersey, United States · 3 investments in Middle East Biotechnology startups

Siddhi Capital is the growth equity partner for convention-crushing food and beverage companies.

Show more...

Investment focus

  • Industry: Food and Beverage, Biotechnology, Nutrition
  • Stage:Seed, Series A, Series B
  • Geography: United States, Israel, Canada

Investor stats

  • Total investments: 55
  • Round size: Seed $1.7M–$6.3M; Series A $5M–$21M; Series B $10M–$106M
  • Lead/follow: 16% lead, 84% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Exosomm — Exosomm is an advanced BioTech-FoodTech startup, located in Israel, that created a food formula for medical purposes, containing patent-based milk exosomes for patients with inflammatory bowel diseases (IBD).
  • BlueNalu — BlueNalu's mission is to be the global leader in cellular aquaculture, providing consumers with great tasting, healthy, safe, and trusted seafood products that support the sustainability and diversity of our oceans.
  • Liberation Bioindustries — Liberation Labs believe that by innovating technology, It can free the world from the costs of industrialized agriculture and unlock a new era of accessible, healthy foods. The mission is to make precision fermentation by commercializing purpose-built manufacturing facilities for industrial biotech.
Show all investments...

SciSparc
VC Fund · Giv'atayim, Tel Aviv, Israel · 3 investments in Middle East Biotechnology startups

SciSparc Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. Our focus is creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. With this focus, the company is currently engaged in the following drug development programs based ontetrahydrocannabinol (THC) and/or non-psychoactive cannabidiol (CBD): THX-110 for the treatment of Tourette syndrome and for the treatment of obstructive sleep apnea; THX-160 for the treatment of pain; and THX-210 for the treatment of autism spectrum disorder and epilepsy.

Show more...

Investment focus

  • Industry: Pharmaceutical, Cannabis, Biopharma
  • Stage:Corporate Round
  • Geography: Israel

Investor stats

  • Total investments: 3
  • Round size: Corporate Round $400k–$700k
  • Lead/follow: 67% lead, 33% follow

Portfolio highlights

  • LaraPharm — LaraPharm Ltd. is a group of people joined together by the belief that active components found in the Cannabis plant can provide a real answer to hundreds of types of disease currently not addressed at all, or poorly addressed.
  • MitoCareX Bio — MitoCareX Bio is a biotechnology company that focuses on the discovery and development of drugs for cancers & other life-threatening diseases.
Show all investments...

ACT Venture Partners
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 3 investments in Middle East Biotechnology startups

Early stage deep tech investor

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Biotechnology
  • Stage:Seed, Series A, Convertible Note
  • Geography: Turkey, United States, United Kingdom

Investor stats

  • Total investments: 39
  • Round size: Seed $345k–$3.2M; Series A $2.4M–$9M; Convertible Note $987k–$1.3M
  • Lead/follow: 74% lead, 26% follow
  • Last fund: May invest from a new fund soon — raised $29M in 2015

Portfolio highlights

  • Nextmol — Nextmol is your partner to accelerate chemicals discovery. Reduce time-to-market and get key insights about the behavior of your chemical molecules!
  • Rototip — On demand CNC manufacturing Rototip Milling Turning Bespoke Manufacturing
  • Picus — The Complete Security Control Validation Platform | Stay proactive by validating your security controls with attack scenarios, empower your Red, Purple, Blue teams.
Show all investments...

fresh.fund
VC Fund · Jerusalem, Yerushalayim, Israel · 3 investments in Middle East Biotechnology startups

fresh.fund is an Israeli pre-seed venture capital fund investing in early-stage startups across segments and verticals.We're built to partner with early-stage founders from day one, often as the company's first institutional investors. Our model is refreshingly simple: up to $300,000 in pre-seed funding within <4 weeks and follow-oncapital as necessary.Check out our portfolio here >> https://www.fresh.fund/portfolio. It's never too early to have a conversation about your startup.

Show more...

Investment focus

  • Industry: Health Care, Artificial Intelligence, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Israel, United States, Norway

Investor stats

  • Total investments: 41
  • Round size: Seed $3M–$12M; Pre-Seed $120k–$6M; Series A $11M–$21M
  • Lead/follow: 12% lead, 88% follow

Portfolio highlights

  • Wisio — Wisio lets social media creators and experts answer questions and requests from followers via paid interactions. The company’s platform empowers followers to gain exclusive access via personalized videos to their favorite creators. Wisio's flexible and easy-to-use platform is packed with features to help creators build deeper communitieswhile monetizing the creator - follower relationship. Thousands of them are already using it to help build their online reputation and business.Wisio's vision is to make everyone reachable.
  • Clearitty — Clearitty - The Ultimate Sales Accelerator by Turning Deal Insights into Revenue We provide the tools and insights for sales executives to close deals faster and outperform competitors, empowering you to drive growth and success. It’s free to start — no trial, no contract, no risk.Clearitty was born out of a shared frustration experienced bysales executives and entrepreneurs alike – the lack of critical insights about new buyers. These invaluable insights are often held by those who have successfully navigated the sales process with these coveted clients.Recognizing the gap, in 2022 we created Clearitty, dedicated to developing an intelligence tool that helps sales executives shorten sales cycles and close deals more efficiently.Our goal is to build the world’s largest database of buyer insights, empowering sales executives with the knowledge they need to succeed.
  • Sherloq — Ask your SQL anything. Built on your context, directly on your editor.
Show all investments...

Binder & Partners Ventures
VC Fund · Paris, Ile-de-France, France · 3 investments in Middle East Biotechnology startups

Binder & Partners Ventures is the investments' capital arm of Binder & Partners multi-family office. The ambition of BPV is to connect our investors with the most promising startup companies.

Show more...

Investment focus

  • Industry: Software, Information Technology, Computer
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Israel, France, United States

Investor stats

  • Total investments: 14
  • Round size: Series A $8M–$14M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Rookout — Code doesn’t always behave as you expect it to and your team is wasting too much time to understand why. Rookout provides secure, fast, and simple data access, no matter what architecture or where the code is running. By providing the developer with instant, laser-focused data, developer teams can understand their code and see an increase inproductivity, velocity, and efficiency.
  • Lumen — Lumen is a device and app that measures your metabolism in a single breath and provides daily personalized nutrition based on your metabolic data. Through the device and app, you can achieve your fitness goals whether they be weight loss, performance optimization, or simply improving your metabolic health.As a company, we are a team ofscientists, researchers, engineers, and designers, aimed at improving the way people understand their metabolism. We believe that a healthy metabolism is a key to better health and that everyone can attain it with a little help from Lumen.At Lumen, we are all about teamwork, friendship, and family. Curious about joining? We are always looking for creative people who share our passion for health and fitness to join our team.
  • Blink Technologies — Blink Technologies is developing a robust, non-intrusive passive, eye-tracking technology without the need for special dedicated hardware. Their non-invasive, AI-based Software Solution can be deployed with any Camera technology on the market today. The proprietary solution integrates with any OS and can run locally (edge-based) or remotely(cloud-based).Blink Technologies was founded in 2018 and is based in Palo Alto, California, United States.
Show all investments...

Cancer Focus Fund
VC Fund · Shreveport, Louisiana, United States · 3 investments in Middle East Biotechnology startups

Cancer Focus Fund is an oncology-focused investment firm advancing breakthrough cancer therapies by partnering with leading scientists, institutions and early-stage companies.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A, Seed
  • Geography: Israel, United States, Germany

Investor stats

  • Total investments: 10
  • Round size: Series A $5.4M–$28M
  • Lead/follow: 60% lead, 40% follow
  • Last fund: May invest from a new fund soon — raised $50M in 2019

Portfolio highlights

  • March Biosciences — Transforming Patient Care by Unlocking New Target Spaces march.biosciences is a clinical-stage company in the cell therapy field focused on developing CAR-T cell strategies to address the most challenging hematological cancers Pipeline MB-105 https://march.bio/wp-content/uploads/2023/05/shutterstock_1008023995-HD-30.mp4 Focused on Excellence Target Space Our approach combines biological and engineering insights to enable target-unlock without the risk and complexity of
  • Starget Pharma — Starget Pharma develops a new generation of targeted radiopharmaceutical technologies for the treatment of solid tumors. Starget Pharma has a pipeline of novel targeted radiopharmaceutical molecules that act as a vector for selectively transferring radioisotopes to cancer tumor tissues.
  • Nectin Therapeutics — NectinTX develops next-generation delivery platforms for immuno-oncology and precision therapeutics. Discover breakthrough protein expression technologies that power safer, more effective treatments.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
FutuRx
VC Fund · Ness Ziona, HaMerkaz, Israel · 3 investments in Middle East Biotechnology startups

FutuRx is the Israeli biotechnology accelerator that was established in 2014 by OrbiMed Israel Partners, Johnson & Johnson Innovation and Johnson & Johnson Development Corporation (JJDC) and Takeda Ventures Inc. following winning the tender of the Office of the Chief Scientist (OCS), Ministry of Economy, in Israel.The incubator willadvance new biotechnology products by identifying and nurturing early-stage life science innovation.FutuRx is located in the Weizmann Science Park in Ness Ziona (near the Weizmann Institute), Israel.

Show more...

Investment focus

  • Industry: Biotechnology, Life Science, Biopharma
  • Stage:Seed
  • Geography: Israel

Investor stats

  • Total investments: 3
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Ramino Bio — Ramino Bio is a private biotech company that develops an oral drug to treat metabolic diseases.Ramino has received funding totaling about $3.3 million since its beginning from the FutuRx biotech incubator, which is supported by the Israeli Innovation Authority, Takeda, J&J, OrbiMed, and RMPG. By speeding up their disintegration, our exclusivetechnology lowers the extra BCAA that is floating around.
  • Protekt Therapeutics — ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.
  • Bsense Bio Therapeutics — Bsense Bio Therapeutics develops small molecules for the treatment of sensory hyperexcitability related disorders. Bsense pioneers a novel approach targeting multiple hyperexcitability-related mechanisms using a single compound, to achieve greater efficacy and safety.
Show all investments...

Kinisis Ventures
VC Fund · New York, New York, United States · 3 investments in Middle East Biotechnology startups

Kinisis Ventures is a venture capital firm backing bold founders building the future. Discover our portfolio, meet our team, and explore how we support startups from seed to scale.

Show more...

Investment focus

  • Industry: Manufacturing, Biotechnology, Internet of Things
  • Stage:Seed, Series A
  • Geography: Cyprus, United States, United Kingdom

Investor stats

  • Total investments: 9
  • Round size: Seed $1.1M–$2M
  • Lead/follow: 67% lead, 33% follow

Portfolio highlights

  • Darefore — Darefore is a technologically advanced brand that has revolutionized cycling performance with a clever position sensor.
  • Threedium — Threedium is a 3D engine. We believe that democratizing the creation and distribution of 3D and AR experiences represents our greatest opportunity to improve the way people buy and sell products.
  • Smartline — The world's most elegant health companion
Show all investments...

Accelmed
VC Fund · Aventura, Florida, United States · 3 investments in Middle East Biotechnology startups

Accelmed is a venture capital firm that funds private and public medical device companies with significant market potential and proven clinical data.Concentrating on medical device companies that have already reached the revenue stage enables the firm to assist companies in benefiting from its managerial capabilities and financial resources.Together with the management teams of their portfolio companies, the Accelmed can steer the way from the clinical-stage to a profitable business with a clear commercial plan, thereby accelerating the path to a successful exit.In 2009, Mori Arkin and Uri Geiger, the co-founders of Accelmed, established the firm in Herzliya, Tel Aviv.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Series D, Series A
  • Geography: Israel, United States

Investor stats

  • Total investments: 36
  • Round size: Series A $695k–$24M; Series D $13M–$96M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • NeuroPace — The NeuroPace RNS System is the only FDA-approved epilepsy device that delivers personalized treatment by responding to abnormal brain activity and provides EEG data that can help improve patient care.
  • UltraClear
  • GT Medical Technologies — GT Medical Technologies, Inc. (GT), an Arizona-based medical device company, is focused on improving the lives of patients with brain tumors. GT has developed an innovative approach to treatment by combining a conformable collagen matrix with brachytherapy (radiation) seeds. The company's first product, GammaTile™ is protected by 10 US and 2Canadian issued patents, and 1 EPO patent. The product has the promise to revolutionize treatment for 176,000 patients/year in the US alone. To date, we have treated 120 patients with recurrent brain tumors in a clinical trial at Barrow Neurological Institute (BNI) and observed significant clinical improvement.
Show all investments...

Nevateam Partners
VC Fund · Herzliya, Tel Aviv, Israel · 3 investments in Middle East Biotechnology startups

NevaTeam Partners is an Agri-Food Tech ESG Impact driven Fund with world-class knowledge and expertise that specializes in identifying and investing in cutting-edge companies and technologies, contributing to the streamlining and increase in world food production in a sustainable way.

Show more...

Investment focus

  • Industry: AgTech, SaaS, Farming
  • Stage:Seed, Series A
  • Geography: Israel

Investor stats

  • Total investments: 5
  • Round size: Seed $5M–$10M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • Brevel — Brevel developed a disruptive cultivation technology for sustainable, low cost and high quality production of microalgae for various yet untapped markets. The technology is based on high-tech indoor, sterile and fully automated systems which are illuminated from within at high intensity. The technology enables the surprising results of more than90% cost reduction and up to 200 higher yields compared to current alternatives. Brevel is using the advantageous production capabilities to enter multiple markets where microalgae derived products are needed.
  • Clarifruit — First automated fruit and vegetable fresh produce quality control software solution by Clarifresh. Optimize your fresh produce QC >>
  • Edete Precision Technologies for Agriculture — edete Precision Agriculture Technologies is solving the world’s ever-growing pollination challenge by developing and manufacturing an efficient, automated fruit orchard pollination system and providing optimized pollination services to companies and growers.By reducing the dependency on haphazard, insect-based pollination processes, edete’scontrolled and manageable mechanical pollination system improves the quantity and quality of fruit orchard yields.
Show all investments...

Milk & Honey Ventures
VC Fund · 3 investments in Middle East Biotechnology startups

Tel-Aviv based investment firm, focused on the effective acceleration of disruptive New Protein technologies

Show more...

Investment focus

  • Industry: Biotechnology, Food and Beverage, Nutrition
  • Stage:Pre-Seed, Seed, Series A
  • Geography: Israel

Investor stats

  • Total investments: 4
  • Round size: Pre-Seed $1.8M–$1.9M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • PoLoPo — PoLoPo is a biotech company that produces proteins on a large scale and according to specifications. PoLoPo develops a "superAA" plant by employing directed metabolic engineering techniques and fully utilizing plants' capacity as various metabolite and green protein factories. A significant amount of free amino acids can be producedby the superAA. The increased production of amino acids is then translated into an increase in the scale at which proteins are produced in plant organs.
  • SuperMeat — SuperMeat is an Israeli bio-tech and food-tech company, developing a technology to create clean meat from chicken cells in a safe and controlled environment, external to the animal’s body. SuperMeat is set to revolutionize the meat industry from its core, aspiring to secure a better future for humans and animals alike. Clean meat is grown in acontrolled, sterile environment without the use of antibiotics and without any possibility of fecal contamination, such as salmonella. Clean meat will require significantly less resources for its production (99% less land, 90% less water), making it both a healthy and sustainable food source for the coming century.
  • Meala Foodtech — Revolutionary texturized plant proteins that replace eggs and hydrocolloids. Clean-label, allergen-free solutions for baking, savory foods, and dressings.
Show all investments...

GlenRock Israel
VC Fund · Herzliya, Tel Aviv, Israel · 3 investments in Middle East Biotechnology startups

A Private Equity Investment Company Founded by Leon Recanati in 2003, GlenRock leverages a unique combination of private equity, multidisciplinary in-house expertise, unmatched access to quality dealflow, and a focused but flexible investment strategy to achieve maximum returns.

Show more...

Investment focus

  • Industry: Software, Cyber Security, Health Care
  • Stage:Seed, Series B, Series A
  • Geography: Israel, United States

Investor stats

  • Total investments: 32
  • Round size: Seed $1M–$19M; Series A $1.5M–$9M; Series B $100k–$12M
  • Lead/follow: 3% lead, 97% follow

Portfolio highlights

  • Treetoscope — The first and only commercial device that senses the internal water flow of a plant and directly measures its water consumption and real-time irrigation needs. without extrapolations based on indirect sensing technologies.Treetoscope offers a SaaS irrigation management platform, based on direct plant sensing technology. We tackle one of the mostcrucial challenges farmers face today: water scarcity and irrigation optimization. Our groundbreaking ag-tech enables the unprecedented measurement of real-time actual water use of trees (based on our patented single probe Sap Flow sensor). Through the Treetoscope solution, growers gain great value as a result of the affordability, scalability, and ease of deployment of our technology.
  • MSICS Pharma — MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for medical purpose.
  • Quris — Quris Technologies is an artificial intelligence (AI) innovator disrupting the pharmaceutical arena.
Show all investments...

Consensus Business Group
VC Fund · London, England, United Kingdom · 3 investments in Middle East Biotechnology startups

Acting as advisor to companies within the Tchenguiz Family Trust, Consensus Business Group has amassed a portfolio of over 300,000 residential freeholds worth over £4 billion and a commercial portfolio worth over £2 billion.Consensus Business Group has vast experience and a proven track record of acquiring stock directly from nationalhousebuilders and developers over 20 years.As a result of their strategic investment, Consensus Business Group is believed to be the largest owner and asset manager of residential freehold interests in the UK, representing in excess of 1% of the housing stock in England and 1.2% in Greater London.Their decisions are not subject to procrastinated board approval or credit committees and as a result they are able to perform quickly and consistently. They are not dependent on debt finance and they have immediate cash availability.Consensus Business Group prides itself on having the market knowledge and expertise to stand out from its competitors, and it is their diligent and efficient acquisition practices that ensure swift transactions.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Seed, Series A
  • Geography: Israel, United States, United Kingdom

Investor stats

  • Total investments: 21
  • Round size: Seed $1.7M–$4.1M; Series A $1M–$10M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • IBI-Ag — IBI-Ag is a biotechnology company developing a new class of bioinsecticides. IBI-Ag is focused on the discovery and development of new types of biological solutions that utilize environmentally friendly technology to control insects. IBI-Ag utilizes breakthrough technology to produce efficient, selective, and safe bio-insect control solutions.IBI-Ag technology is highly cost-effective due to its fermentation suitability enabling farmers to produce agricultural produce at a low cost.
  • MEDX Xelerator — MEDX Xelerator is a unique medical device and digital health incubator. It was founded by MEDX Ventures Group, together with three partners: Boston Scientific, Intellectual Ventures’ Invention Science Fund and Sheba Medical Center. Each of MEDX Xelerator’s partners contributes outstanding core competencies, which complement one another and togethercreate a solid foundation for your success. Our incubator is seeking medical innovations for minimally invasive procedures, medical robotics, medical implants and digital health.Our vision is to leverage the power of MEDX Xelerator, and together with the extraordinary Israeli med tech innovation scene create a local cluster of entrepreneurial companies with breakthrough solutions to true unmet medical needs. Our mission is to nurture those promising technologies into successful medical ventures for the benefit of patients and health care professionals. We see you, the entrepreneur, as the key to success and we are here for you to make it happen.
  • Synchrony Medical — Synchrony Medical is a clinical stage medical device company developing LibAirty, a next generation, home-use, airway clearance system designed to help patients with chronic lung disease such as COPD and CF maintain clear lungs with a short, daily, proficient treatment.
Show all investments...

Neo Ventures
VC Fund · Sofia, Grad Sofiya, Bulgaria · 3 investments in Middle East Biotechnology startups

Neo Ventures is the first open-ended early stage investor, based in Eastern Europe. The founders have backed more than 30 startups and exited 10 successfully. We invest in game-changing businesses, without geographic limitations. We partner with exceptional founder teams to challenge incumbents in markets ripe for change or to create entirely newmarkets. Neo Ventures funds and then supports the founders in business planning, scaling operations, follow-on investments, making the best of each opportunity and dealing with hard situations. Our investment focus is on data analytics, computer vision and remote sensing addressing disruptive opportunities across the high-growth SpaceTech, BioTech and Security verticals.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Aerospace
  • Stage:Seed, Series A
  • Geography: Israel, United Kingdom, Estonia

Investor stats

  • Total investments: 13
  • Lead/follow: no public data

Portfolio highlights

  • EnduroSat — At EnduroSat, we engineer, build and operate exceptional satellites. Our Mission is to make space universally accessible
  • Cyberwrite — TRUSTED BY INDUSTRY LEADERS One platform to accelerate value across the cyber insurance lifecycle THE LATEST FROM CYBERWRITE
  • GemmaCert — The easy-to-use GC-PRO by GemmaCert for quick and accurate potency analysis of cannabis and hemp, including for THC, CBD, and CBG.
Show all investments...

Ziegler Meditech Equity Partners
VC Fund · Milwaukee, Wisconsin, United States · 3 investments in Middle East Biotechnology startups

Ziegler is a privately held investment bank, capital markets and proprietary investments firm.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Mobile
  • Stage:Series C, Series E, Series F
  • Geography: United States, Israel

Investor stats

  • Total investments: 6
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • Aposense — Aposense (formerly NST) is a clinical-stage molecular imaging and drug development company, with a pipeline of products based on its patented platform technology for targeting apoptosis (programmed cell death) in vivo. The company translating the science of Apoptosis (programmed cell death) into personalized patient care in multiple diseasecategories, including oncology, cardiology, and neurology. Targeting of this important biological process in-vivo opens opportunities for real-time clinical imaging of disease activity and targeted therapy.Aposense specializing in the development of novel drugs and utilizing membrane electrical forces for trans-membrane of macromolecule drugs, mainly siRNA. It also developed rationally-designed molecular nano-motors (MNMs), being novel small-molecule chemical entities and its translation into kinetic energy for movement within the hydrophobic membrane core.Aposense was founded in 1996 and is headquartered in Petah Tiqva, HaMerkaz, Israel.
  • MAKO Surgical — MAKO Surgical is a medical device company, markets its advanced robotic arm solution, joint specific applications for the knee and hip, and orthopedic implants for orthopedic procedures in the United States and internationally. The company offers MAKOplasty, a restorative surgical solution that enables orthopedic surgeons to treat patient specificosteoarthritic disease. It also provides robotic arm interactive orthopedic system (RIO) consisting of a tactile robotic arm utilizing an integrated bone cutting instrument; and a patient specific visualization component, which offers pre-operative and intra-operative guidance to the orthopedic surgeon, enabling tissue sparing bone removal, and accurate implant insertion and alignment.In 2011, The company was named the No.1 on the Technology Fast 500 as the fastest growing technology company by Deloitte and received the CSSEC Award for loyal, customer-focused staff members presented by the Technology Services Industry Association and ACE Award (Achievement in Customer Excellence) from MarketTools and Fast Tech Award as one of the 25 fastest growing technology companies in South Florida by South Florida Business Journal.MAKO Surgical was founded in 2004 and is headquartered in Florida, USA.
  • MobileAccess Networks — Corning Everon Network Solutions offer in-building cellular solutions to meet a broad array of design scenarios and mitigate RF propagation challenges.
Show all investments...

EIT Food
VC Fund · Belgium, Wisconsin, United States · 3 investments in Middle East Biotechnology startups

EIT Food is a European Knowledge and Innovation Community (KIC), which was set up to transform our food ecosystem. By connecting consumers with businesses, start-ups, researchers and students from around Europe, EIT Food supports innovative and economically sustainable initiatives which improve our health, our access to quality food, and our environment

Show more...

Investment focus

  • Industry: Food and Beverage, Biotechnology, Food Processing
  • Stage:Grant, Seed
  • Geography: United Kingdom, Israel, Germany

Investor stats

  • Total investments: 86
  • Round size: Seed $226k–$11M; Grant $30k–$572k
  • Lead/follow: 63% lead, 37% follow

Portfolio highlights

  • BettaF!sh — BettaF!sh is the first company developing 100% plant-based tuna alternatives mainly created with seaweed from Europe.
  • Hooked Foods — Leading the transition to a harmless seafood system by serving healthy vegan seafood for everybody to truly enjoy.
  • New Wave Biotech — New Wave Biotech's AI Downstream Process Optimization Software empowering SynBio innovators to get to market quicker, better and at lower cost. By simulating bioprocesses, techno economic analysis and auto optimisation, we help precision fermented alternative protein and other industrial biotechnology products improve yield and scale production.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
SOSV
VC Fund · Princeton, New Jersey, United States · 3 investments in Middle East Biotechnology startups, 75 in the past 12 months

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Convertible Note, Pre-Seed
  • Geography: United States, India, United Kingdom

Investor stats

  • Total investments: 1482
  • Lead/follow: no public data

Portfolio highlights

  • MixRift — MIXRIFT - game developers specialized in Mixed Reality
  • unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
  • Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Show all investments...

Istcapital
VC Fund · Capelle Aan Den Ijssel, Zuid-Holland, The Netherlands · 3 investments in Middle East Biotechnology startups

ISTcapital is a family office-backed venture capital firm partnering with exceptional founders to build early-stage, global technology companies.

Show more...

Investment focus

  • Industry: Biotechnology, Beauty, Gaming
  • Stage:Seed, Series A
  • Geography: Turkey, United States

Investor stats

  • Total investments: 7
  • Round size: Seed $1M–$2.5M
  • Lead/follow: 43% lead, 57% follow

Portfolio highlights

  • Cellestetix — Cellestetix is a biotech company that specializes in developing and commercializing plant-based exosome formulas for regenerating skin, hair, and wellness.
  • Spline — Spline is a free 3D design software with real-time collaboration to create web interactive experiences in the browser. Easy 3d modeling, animation, textures, and more.
  • PhiTech Bioinformatics — PhiTech pioneers the integration of DNA & RNA sequencing data with AI for rare disease diagnostics. We offer the first RNA-based diagnostic support tool.
Show all investments...

Pitango VC
VC Fund · Herzliya, Tel Aviv, Israel · 3 investments in Middle East Biotechnology startups

Pitango VC is a venture capital firm focused on health-tech (Pitango Health-tech) and growth (Pitango Growth) investments in startups around the world in domains such as vertical SaaS, digital health, deep tech, fintech and insurance technology, devops, generative AI, Web3, and food tech.With two offices in Israel, Pitango currently managesseveral venture funds totaling over $2.8 billion in committed capital. It has invested in more than 250 companies.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Series A, Series B, Series C
  • Geography: Israel, United States, China

Investor stats

  • Total investments: 277
  • Round size: Series A $4M–$47M; Series B $7.5M–$44M; Series C $8.2M–$100M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely still investing — raised $175M in 2023

Portfolio highlights

  • Nexite — Nexite develops a platform that provides item tracking, inventory transparency and business intelligence from manufacturing to the customer's home. Its miniature NanoBT batteryless tag can be read by any smartphone, costs a fraction of the cost of similar tags, and is small enough to embed into the item. The company was founded in 2017 andis headquartered in Tel Aviv, Israel.
  • Sayata — Sayata delivers rapid growth to brokers and carriers that place commercial risk.The Sayata platform streamlines the quote-bind-issue process allowing insurance professionals to seamlessly place commercial risk in a fraction of the time.Sayata provides an end-to-end technological solution along with educational tools, giving our partners theability to grow their book quickly and efficiently.To date, over 1,000 users across 75 brokerages and carriers partner with Sayata to grow their commercial book.
  • Topspin Medical — TopSpin Medical developed an innovative and unique technology for high-resolution MRI using an IntraVascular MRI (IVMRI) catheter for the coronary arteries, without the need for an expensive and bulky external MRI setup. The catheter contains those components, which are usually found in a conventional MRI scanner, only that they are miniaturizedto less than 2 millimeters in size.
Show all investments...

Aurum Ventures MKI
VC Fund · Ramat Gan, Tel Aviv, Israel · 2 investments in Middle East Biotechnology startups

Morris Kahn bussiness in Aurum Ventures MKI and The Kahn Foundation an independent private philanthropic foundation.

Show more...

Investment focus

  • Industry: Biotechnology, Medical Device, Information Technology
  • Stage:Seed, Series A, Series C
  • Geography: Israel

Investor stats

  • Total investments: 6
  • Lead/follow: no public data

Portfolio highlights

  • Nucleix — OUR TESTS AIM TO DETECT CANCER EARLIER - WHEN TREATMENT CAN BE MOST EFFECTIVE FOR PATIENTS OUR PRODUCTS
  • Scopio Labs — Scopio Labs is a provider of Full Field Morphology dedicated to unlocking the potential of imaging and AI in hematology. Uncovering actionable insights from vast amounts of data readily available in the average blood sample and bone marrow aspirate, Scopio's solutions will aim to showcase thousands of cells at scale in high resolution, toenable new hematology diagnostic methods.
  • KidneyCure — KidneyCure offers a novel dimension to treating advanced Chronic Kidney Disease.
Show all investments...

MoreVC
VC Fund · Ra'anana, HaMerkaz, Israel · 2 investments in Middle East Biotechnology startups

MoreVC invests in seed and early stage Israeli technology start-ups, partnering with entrepreneurs who are building companies that matter.

Show more...

Investment focus

  • Industry: Software, Energy, Renewable Energy
  • Stage:Series A, Seed
  • Geography: Israel, United States, Canada

Investor stats

  • Total investments: 60
  • Lead/follow: no public data

Portfolio highlights

  • Gavan — Transforming the way proteins are delivered. Our technology extracts high purity proteins from source while maintaining their physical structure unharmed and preserving their high functionality.
  • Ubeya — Ubeya is an employee management platform that helps manage shift and hourly employees. Offering an and-to-end solution for Staffing Agencies, Catering and Hospitality industries, Delivery Fleets, and more. Helping Managers, Payroll, HR and Legal departments to digitize operations with an employee app and a client portal. Our modular system allows each business to choose the functions that best serve their business: Schedule, Clock-in, Track, Communicate and Pay your employees with Ubeya.
  • Quinn — hyve is your new favorite money app that uses the power of your people to help you save, invest, and get out of debt way faster! Download the app today.
Show all investments...

Endure Capital
VC Fund · Cairo, Al Qahirah, Egypt · 2 investments in Middle East Biotechnology startups

Endure Capital is an early stage investment fund headed by entrepreneurs looking for startup teams. They look for founders who are relentlessly resourceful and imaginative, solving genuine problems that matter to a lot of people and building high growth companies that endure.

Show more...

Investment focus

  • Industry: Software, Health Care, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: Egypt, United States, United Kingdom

Investor stats

  • Total investments: 74
  • Lead/follow: no public data

Portfolio highlights

  • Pyka — We believe that electrification and automation will make aviation safer, more affordable, and more accessible than has ever been possible in human history.
  • ShopLook — Online personal styling destination. Discover outfit ideas or virtually create your own using our outfit maker.
  • Cash Cows — Cash Cows helps startups hone their operations and strategies so they can expand profitably and create better brands. They collaborate with customers to close the gap between traditional business practices (experience) and cutting-edge approaches (solutions), allowing companies to operate successfully.
Show all investments...

Chartered Opus
VC Fund · Düsseldorf, Nordrhein-Westfalen, Germany · 2 investments in Middle East Biotechnology startups

Chartered Opus offers professional market participants (clients such as asset managers) the opportunity to realise “securitised” concepts/products for their own investment or for their customers.

Show more...

Investment focus

  • Industry: Wellness, Biotechnology, Manufacturing
  • Stage:Series A
  • Geography: Israel

Investor stats

  • Total investments: 3
  • Lead/follow: no public data

Portfolio highlights

  • SolCold — We make the sun cool again - Solcold the new environment solutions
  • Trobix Bio — Trobix Bio is a company that develops and commercializes antibacterial products. It has developed platform technologies called ActiSense and GOTrap for developing high-quality products that remove the threat of antimicrobial resistance.
Show all investments...

The Food Tech Lab
VC Fund · Spain, Georgia, United States · 2 investments in Middle East Biotechnology startups

The Food Tech Lab (TFTL), is an investment club formed by a network of investors, mostly professionals linked to the agri-food sector.

Show more...

Investment focus

  • Industry: Biotechnology, Manufacturing, Food and Beverage
  • Stage:Seed, Pre-Seed
  • Geography: Israel, Spain, Sweden

Investor stats

  • Total investments: 6
  • Lead/follow: no public data

Portfolio highlights

  • Brevel — Brevel is leading the way with its breakthrough fermentation technology, offering delicious, affordable and sustainable protein.
  • Pack2Earth — Pack2Earth, S.L. is a company that specializes in developing new, sustainable materials for the food sector and other industries.
  • BlueRedGold — Discover BlueRedGold - the home of exquisite Swedish Saffron, ethically grown and harvested with precision in Sweden. Experience the unparalleled quality of our saffron, perfect for culinary enthusiasts and chefs alike. Join us in embracing sustainable luxury.
Show all investments...

HackCapital
VC Fund · Lausanne, Vaud, Switzerland · 2 investments in Middle East Biotechnology startups

Join FoodTech focused investors looking to back impact-driven founders shaping our food system

Show more...

Investment focus

  • Industry: Biotechnology, Food and Beverage, Food Processing
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, Israel, United Kingdom

Investor stats

  • Total investments: 26
  • Lead/follow: no public data

Portfolio highlights

  • twig bio — twig bio operates as a bioengineering startup. twig bio using AI and robotics to find sustainable replacements for harmful ingredients.
  • RAAAM Memory Technologies Ltd. — RAAAM provides a unique on-chip memory technology that offers the highest-density embedded memory solution in any standard CMOS process.RAAAM develops a high-density memory technology that allows for up to 50% higher on-chip memory density with no cost, complexity, or performance-penalty.
  • Cultivated Biosciences — Cultivated - Creamy, dairy-free indulgence
Show all investments...

Arancia International
VC Fund · Guadalajara, Jalisco, Mexico · 2 investments in Middle East Biotechnology startups

Arancia International Inc is a part of Arancia Group in Mexico. We are long term investors in food, nutrition and biotechnology companies.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Life Science
  • Stage:Series A, Series B
  • Geography: Israel, United States, Malaysia

Investor stats

  • Total investments: 9
  • Lead/follow: no public data

Portfolio highlights

  • NextFerm — NextFerm is a science oriented industrial company, representing a new era in fermentation and fermentation-derived nutrients for supplements, food, infant nutrition and animal feed.The world is striving for better nutrition. Nutrition which is less artificial and more natural, sustainable and cost effective - with a much higher nutritional value.At Nextferm, they aim to use their capabilities to lead this new and exciting world of better nutrition.
  • iwi Life — Algae is the ultimate source of Omega-3s. Research has proven that Omega-3s support cardiovascular health, a balanced mood, and healthy brain development.
  • The Mediterranean Food Lab — The Mediterranean Food Lab merge traditional fermentation and cutting-edge science, to produce natural plant-based flavor-bases for a wide range of meat replacement needs.
Show all investments...

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotechnology VC Funds in Middle East investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 48,091 VC funds investing in Middle East Biotechnology startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists